INTERDISCIPLINARY DRUG DISC
Stanford University ยท CA ยท BIOS250
INTERDISCIPLINARY DRUG DISC is a subject at Stanford University, CA in [object Object]. It covers topics like alternative-dispute-resolution, clinical-pharmacy, criminal-law, pharmacology. It is part of 1 degree. The information below is compiled from public course material โ approximate, not official.
Stanford University
BIOS250
1.00
[object Object]
Topics covered
Degrees that include INTERDISCIPLINARY DRUG DISC
Frequently asked questions
What is INTERDISCIPLINARY DRUG DISC about?
INTERDISCIPLINARY DRUG DISC covers topics like alternative-dispute-resolution, clinical-pharmacy, criminal-law, pharmacology.
Which degrees include INTERDISCIPLINARY DRUG DISC?
INTERDISCIPLINARY DRUG DISC is part of 1 degree, including Multi-Interdiciplinary (GRVR).
How many credit points is INTERDISCIPLINARY DRUG DISC?
INTERDISCIPLINARY DRUG DISC at Stanford University is typically around 1.00 credit points. Approximate โ confirm with the university.
Where is INTERDISCIPLINARY DRUG DISC taught?
INTERDISCIPLINARY DRUG DISC is taught at Stanford University, CA.
Studying INTERDISCIPLINARY DRUG DISC?
Peernovo helps students research, choose and thrive at university โ across Australia, the US, the UK and Canada โ powered by our AI backbone:
- Explore & compare degrees โ across universities and countries with honest, specific information.
- "What Can I Be?" career guidance โ an AI pathway councillor that maps degrees to careers.
- See who's studying โ your degree at your university โ find classmates and study groups.
- AI Task Coach โ a Socratic study companion that plans your work around your life.
- Honours & Thesis Research Coach โ structure and move your research project forward.
- Smart study planner, exam prep and a daily digest โ to keep you on track.
Sources: Stanford University public course catalogue. Information is compiled and summarised โ not copied verbatim โ and is approximate; always confirm with the original source.
Something not right on this page, or want it changed? Let us know and we'll review it.
